Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) Trial Investigators Long-term Use of Low-dose Aspirin Develops Proteinuria in Patients With Diabetes: A Reanalysis of JPAD Study.
Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) Trial Investigators Long-term Use of Low-dose Aspirin Develops Proteinuria in Patients With Diabetes: A Reanalysis of JPAD Study.
复制标题
日本用阿司匹林治疗糖尿病的动脉粥样硬化一级预防 (JPAD) 试验研究人员长期使用低剂量阿司匹林会导致糖尿病患者出现蛋白尿：JPAD 研究的重新分析。
DOI：
--
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
Saito Y.
中科院分区：
文献类型：
--
作者：
Okada S;Morimoto T;Ogawa H;Sakuma M;Soejima H;Ohtorii M;Nakayama M;Doi N;Akai Y;Jinnouchi H;Waki M;Sugiyama S;Uemura S;Saito Y.
